WOOJUNG BIO Balance Sheet Health
Financial Health criteria checks 1/6
WOOJUNG BIO has a total shareholder equity of ₩22.0B and total debt of ₩50.7B, which brings its debt-to-equity ratio to 230.5%. Its total assets and total liabilities are ₩98.3B and ₩76.4B respectively.
Key information
230.5%
Debt to equity ratio
₩50.65b
Debt
Interest coverage ratio | n/a |
Cash | ₩5.75b |
Equity | ₩21.97b |
Total liabilities | ₩76.36b |
Total assets | ₩98.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A215380's short term assets (₩19.7B) do not cover its short term liabilities (₩45.7B).
Long Term Liabilities: A215380's short term assets (₩19.7B) do not cover its long term liabilities (₩30.7B).
Debt to Equity History and Analysis
Debt Level: A215380's net debt to equity ratio (204.4%) is considered high.
Reducing Debt: A215380's debt to equity ratio has increased from 40.5% to 230.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A215380 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A215380 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16% each year